Gruppo Oncologico Dell'Italia Meridionale

The sponsor’s clinical research is centered on metastatic colorectal cancer, with a strong focus on treatment strategies for patients with advanced disease and prior treatment exposure.

• RAS/BRAF wild-type disease
• Second-line and later-line treatment
• Biomarker-selected patient populations

Its studies address molecularly defined subgroups within metastatic colorectal cancer, reflecting a sustained interest in precision-oriented oncology care.